TODD STRATEGY GROUP

Lobbying for OTSUKA AMERICA PHARMACEUTICAL, INC. · Pharmaceutical Manufacturer.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Drug Pricing Policy. Issues relating to mental health as a chronic condition. Agitation in Alzheimer's.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.